Leading Imperial Academics are featured in the New Year Honors List 2022.
This story will be updated
Members of the imperial community who receive honors include Professor Robin Grimes, BCH Steele Chair of Energy Materialss in the materials departmentwho got a Knight Bachelor degree for services United Kingdom Resilience and International Academic Relations.
Professor Wendy Barclay, Director of Infectious Diseases at Imperial College London and Professor of Influenza Virology, has been awarded a CBE for her contributions to virus research and research during the COVID-19 pandemic. Professor Peter Openshaw, Professor of Experimental Medicine at Imperial’s National heart and Lung Institute, also receives a CBE for medical and immunology services.
Dr. Justin Roe, Honorary Clinical Senior Lecturer in the Department of Surgery and Cancer at Imperial, receives an MBE in Speech Therapy Services, while Lesley Rawlinson, LLaboratory manager in Imperial’s Department of Infectious Disease receives a British Empire Medal for COVID-19 response services.
Knighthood: Professor Robin Grimes
Professor Robin Grimes’ Research focuses on the application and development of computer simulation techniques for predicting structural and dynamic properties of ceramics and metals for energy applications – especially nuclear.
He has been an author since 1984 over 300 peer-reviewed publications. He was Chief Scientific Adviser (Nuclear) to the Department of Defense and Chief Scientific Adviser to the Foreign and Commonwealth Office.
Professor Grimes continues play an active role in building relationships with scholars around the world including Japan, Argentina and India. In 2021 he was elected Foreign Minister of the Royal Society.
Professor Robin Grimes said: “I am grateful to mine Excellent Colleagues and too the environment at Imperial that enabled me to do this important work within Government. I am honored to receive this recognition. “
Professor Wendy Barclay CBE
Early in her career at what was then the Common Cold Unit at Salisbury and the University of Reading, Professor Barclay’s research focused on respiratory viruses and the factors that affect how well they are transmitted and can cause disease.
In nearly 15 years at Imperial, her work has provided important insights into the molecular aspects of the host spectrum, Transmittability and pathogenicity of viruses such as influenza, rhinovirus and SARS-CoV-2. She has helped understand how these viruses cause pandemics and how we can best use vaccines and antiviral treatments to fight them.
It was the proudest moment of my life to tell my husband and two sons that I am honored this way. ” Professor Wendy Barclay Infectious Diseases Department
During the COVID-19 pandemic, her collaboration with Public Health England (now the UK Health Security Agency) and her role on several government councils have provided critical evidence of emerging threats from SARS-CoV-2 and its variants. This work includes basic virology and immunology as well as the analysis of environmental samples for traces of the virus.
Professor Barclay’s team is playing a key role in Imperial’s COVID-19 response and continues to work on molecular analysises for projects like: the REACT study to monitor virus and antibodies in the community; ATACCC investigates household transmission; ISARIC-4C, which collects and analyzes samples from hospitalized COVID-19 patients; and the COVID-19 Human Challenge Study.
they also is a member of National core study on the transmission of SARS CoV2, PROTECT and you leads the UK Genotype to phenotype virology (G2P) Consortium founded to research the Effects of mutations in the SARS-CoV-2 coronavirus and help UKHSA risk assessing new variants in real time as they arise..
In honor of her honor, Professor Barclay said: “I am really grateful to have been nominated for this award. The past two years have been very busy and I couldn’t have achieved anything without the unwavering support of the people I work with, my laboratory, and my old and new staff. But especially my family – it was the proudest moment of my life to tell my husband Dan and my two sons Harry and Fergus that I was honored this way. ”
Professor Peter Openshaw CBE
Professor Peter Openshaw is a respiratory medicine and mucosal immunologist who studies how the immune system protects against viral infections as well as causes disease. He was a central figure in Imperial’s COVID-19 response and provided crucial insight into the progression and spread of the disease.
Professor Openshaw said, âI am delighted to receive this award, which not only recognizes my work, but also the fantastic teams I have worked with over many years. It is wonderful to have recruited a number of brilliant young investigators who are now academic leaders in their own right or have taken on enjoyable roles in other areas. “
He is a co-leader ISARIC4C a UK consortium of doctors and scientists founded in 2020 to model the COVID-19 pandemic on the MOSAIC consortium which he founded in 2009 to study pandemic influenza. ISARIC4C provides a foundation for the UK outbreak response and shares samples and data to help researchers around the world respond to pressing questions about COVID-19 quickly, openly and for the public benefit.
Professor Openshaw has been working on RSV and influenza since the mid-1980s and has been conducting studies on experimental human infection of volunteers since 2008. He is the director of the MRC-funded HIC-Vac consortium, which was created to promote the use of experimental human infections to accelerate vaccine development for pathogens with major global impact. He is the co-investigator for a landmark human challenge study for COVID-19 at Imperial, which helps to understand the course of the disease in people with mild infections and to study the detailed natural course of SARS-CoV-2 infection.
Professor Openshaw is vice chairman of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG), which advises the government on the threat posed by new and emerging respiratory viruses. From 2013 to 2018 he was President of the British Society for Immunology.